Answer
Tirofiban hydrochloride monohydrate blocks the platelet-surface GP IIb/IIIa receptor, preventing fibrinogen binding and thereby blocking platelet aggregation.
Sources for this answer
- Aggrastat 250 mcg/ml Concentrate for Solution for InfusionADVANZ Pharma · emc · SmPC §5.1 Pharmacodynamic properties · Version 16Document updated
Sources checked